Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indegene was identified as a Leader in the ISG Provider Lens™ 2026 report for Life Sciences Digital Services in Commercial Operations. This recognition for the third consecutive year highlights the company's strong domain expertise and use of AI/GenAI.
May 04 2026 17:05:00
Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Indegene announced the audio recording of its Q4 and Annual FY26 earnings call, held on April 30, 2026, is available. This provides investors access to the post-results discussion and management commentary.
Apr 30 2026 11:04:00
Indegene Limited
Indegene Limited submitted its Q4 FY26 Monitoring Agency Report on IPO proceeds utilization to SEBI. The report noted deviations in fund allocation from the original offer document, which were subsequently approved by shareholders. Approximately Rs.17.26 crore from the IPO proceeds remains unutilized.
Apr 29 2026 21:04:00
Indegene Limited
INDEGENE LIMITED board approved a final dividend of Rs. 112.5 per equity share. The record date for this dividend will be announced subsequently.
Apr 29 2026 20:04:00
Indegene Ltd - 544172 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indegene announced strong Q4 FY26 and full-year FY26 results, with Q4 revenue rising 32.8% YoY to Rs.1,003.4 crore and full-year revenue reaching Rs.3,510.5 crore. The board also recommended a final dividend of Rs.2.25 per share for FY26, reflecting robust financial performance and operating fundamentals.
Apr 29 2026 20:04:00
Indegene Ltd - 544172 - Board Meeting Outcome for Outcome Of Board Meeting
Indegene's board approved Q4 FY26 results, reporting ₹10,142 mn revenue (up 29.8% YoY) and ₹797 mn net profit (down 32.2% YoY). The company also recommended a final dividend of ₹2.25 per share, resulting in a total cash outflow of ₹542 mn.
Apr 29 2026 20:04:00
Indegene Limited
Indegene Limited board to meet on April 29, 2026, to consider a final dividend and audited FY26 standalone and cons. financial results.
Apr 21 2026 18:04:00
Indegene Ltd - 544172 - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results Of The Company And Recommendation Of Final Dividend For The Year Ended March 31, 2026.
Indegene Limited's board is scheduled to meet on April 29, 2026. The agenda includes approving Q4 and FY26 financial results and recommending a final dividend. The meeting will also consider both audited consolidated and standalone financial results.
Apr 21 2026 17:04:00
Read More